A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma. [electronic resource]
Producer: 19880620Description: 1-6 p. digitalISSN:- 0090-8258
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bleomycin -- administration & dosage
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Clinical Trials as Topic
- Combined Modality Therapy
- Female
- Humans
- Middle Aged
- Mitomycin
- Mitomycins -- administration & dosage
- Neoplasm Staging
- Uterine Cervical Neoplasms -- drug therapy
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.